Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-10 21:00:16 ET
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call March 10, 2026 4:30 PM EDT
Company Participants
Punit Dhillon - President, CEO, Principal Accounting Officer & Director
Christopher Twitty - Chief Scientific Officer
Tu Diep - Chief Operating Officer
...
Read the full article on Seeking Alpha
For further details see:
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call Transcript
Skye Bioscience Inc Com
NASDAQ: SKYE
SKYE Trading
-1.43% G/L:
$0.6823 Last:
204,031 Volume:
$0.7213 Open:
SKYE Latest News
March 10, 2026 04:01:00 pm
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 05, 2026 07:00:00 am
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
February 02, 2026 07:00:00 am
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
SKYE Stock Data
$23,264,099
19,202,419
2.95%
18
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
